Who
Gary D. Glick
Director and Officer
Company insider
Files Form 4 as: Director and Officer, Odyssey Therapeutics.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 May 2026
- Last trade
- 11 May 2026
- Last filed
- 11 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 May 2026filed 11 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code C | —27,386 | filing |
| 11 May 2026filed 11 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —100,000 | filing |
| 11 May 2026filed 11 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —166,116 | filing |
| 11 May 2026filed 11 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —100,000 | filing |
| 11 May 2026filed 11 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —166,116 | filing |
| 11 May 2026filed 11 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code C | —27,386 | filing |
| 7 May 2026filed 11 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —884,450 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —884,450 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.